Artelo Biosciences (ARTL) announced the presentation of preliminary data on ART27.13, the Company’s benzimidazole derivative, being studied for cancer-related anorexia. The data was presented by ...
“With no therapies approved to treat cancer-related anorexia in the UK, US, or Europe, I am impressed by the effect of ART27.13 at low doses in the majority of the participants in CAReS ...
"With no therapies approved to treat cancer-related anorexia in the UK, US, or Europe, I am impressed by the effect of ART27.13 at low doses in the majority of the participants in CAReS,” commented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback